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ABSTRACT
 ةيضقك  تاداضملل  ةمواقلما  تابوركيلما  ىلع  ءوضلا  طيلست  ديازَت
 ىلجتي  .ملاعلا  ءاحنأ  عيمج  يف  رشبلا  ةحصلو  ناويلحا  ةحصل  ةحلُم
 ةيويلحا تاداضلما مواقت يتلا ايريتكبلا يف حضاو لكشب عوضولما اذه
 يف جلاعلل ةلباق ريغ ىودعب ءىبني امم .ريخأ رايخك اهمادختسا دنع
 تابوركيلما ةحفاكلم تايجيتارتسا ةيلودلا تلااكولا تحرتقأ .لبقتسلما
 ةيبرعلا  ةكلملما  يف  تايدحتلا  نم  ديدعلا  كانه  .تاداضملل  ةمواقلما
 ةيودلأل ةمواقلما ايريتكبلا راشتناو روهظ زفتح نأ نكيم يتلا ةيدوعسلا
 تاعاطق  نم  دوهجم لذب  نم  دبلا تايدحتلا  هذه  ةهجاولم  .ةددعتلما
 ةمواقلما  تابوركيلما  روهظو  راشتنا  ىلع  حاجنب  ةرطيسلل  ةددعتم
 روهظ  عبتتل  ةلاّعفلا  ةبقارلما  تاءارجلإا  نمضتت  نأ  دبلا  .تاداضملل
 ينستح يف ةيولولأا ءاطعإ نم ًاضيأ دبلاو .اهراشتناو تابوركيلما هذه
 نم  .اهراشتنا  نم  دحلل  اهتحفاكمو  ىودعلا  نم  ةياقولا  تاطايتحا
 ريغ ةيويلحا تاداضلما مادختسا نم دحلل يعولا ىوتسم عفر يرورضلا
 ،تايفشتسلما يف ةيويلحا تاداضلما ةرادإ جمارب ىلع يغبنيو ،ةبسانلما
 رمتسلما  مادختسلاا  ميظنت  تايلديصلاو  ،ةيجرالخا  تادايعلاو
.ةيويلحا تاداضملل
Antimicrobial resistance (AMR) is increasingly being 
highlighted as an urgent public and animal health 
issue worldwide. This issue is well demonstrated in 
bacteria that are resistant to last-line antibiotics, 
suggesting a future with untreatable infections. 
International agencies have suggested combating 
strategies against AMR. Saudi Arabia has several 
challenges that can stimulate the emergence and 
spread of multidrug-resistant bacteria. Tackling 
these challenges need efforts from multiple sectors 
to successfully control the spread and emergence of 
AMR in the country. Actions should include active 
surveillance to monitor the emergence and spread of 
AMR. Infection prevention and control precautions 
should also be optimized to limit further spread. 
Raising awareness is essential to limit inappropriate 
antibiotics use, and the antibiotic stewardship 
programs in hospital settings, outpatients, and 
community pharmacies, should regulate the ongoing 
use of antimicrobials.
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Antimicrobial resistance (AMR) in bacteria is emerging and spreading rapidly worldwide. This 
phenomenon is nowadays affecting public and animal 
health dramatically on a global level. The discovery 
of penicillin in the last century provided significant 
advancements in modern medicine, as well as our ability 
to treat commonly encountered infectious diseases, 
one of the biggest killers during the pre-antibiotics 
era. Many of life-saving interventions, such as cancer 
chemotherapy and major surgeries depend on effective 
antimicrobials to succeed.1 Unfortunately however, 
the current dependence on antibiotics - whether to 
treat, prevent, or stimulate food animal growths - 
have exponentially increased this resistance. When 
antibiotics are used, selective pressure is created, and 
possibly forcing the exposed bacteria to mutate or 
acquire pieces of DNA to become antibiotic resistant.2 
The selection pressure resulting from the overwhelming 
use and misuse of antibiotics is exponentially supporting 
the AMR phenomenon.3 Despite this known fact, 
approximately 10 million tons of antibiotics are globally 
used every 10 minutes, which mostly are not related to 
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justified medical use.4 As a result to the global march 
of AMR, common infections, such as urinary-tract 
infections are becoming difficult to treat. This is mainly 
due to bacteria that are resistant to last-line antibiotics,2 
or even pan-drug resistant that are not responding to 
any commercially available antibiotics.5 The multidrug-
resistant (MDR) pathogens are spreading rapidly in 
many parts of the world causing severe medical and 
economic consequences. It is estimated that at least 
every 10 minutes a patient dies in the USA or Europe 
because of fatal infections caused by antibiotic resistant 
bacteria.6 This article gives a brief overview on the 
current situation of AMR in Saudi Arabia and the 
immediate actions needed to tackle this issue.
The emergence and spread of AMR bacteria 
in Saudi Arabia. Current and future challenges. A 
systematic literature review of MDR in Gram-negative 
bacilli (GNB) showed a substantial increase in the rate 
of carbapenem-resistant GNB in Saudi Arabia over the 
last decade in comparison with the rates of the 1990s. It 
also documented the increasing prevalence of extended 
spectrum beta-lactamase (ESBL) producing isolates 
from Saudi Arabia, where some institutes had 29% ESBL 
rates among Escherichia coli (E. coli) and 65% ESBL 
rates among Klebsiella pneumoniae (K. pneumoniae). As 
a result, these increasing rates have been associated with 
many reported outbreaks and mortality that ranged 
between 11-40%.7
Recent region-wide surveillance studies reported that 
most of carbapenem resistant Enterobacteriaceae (CRE) 
from the Gulf Cooperation Council States (GCC) have 
been found to harbor the carbapenemase encoding 
genes blaOXA-48-type, and blaNDM-1.
8 Carbapenem resistant 
Acinetobacter baumannii (A. baumannii) (CRAB) from 
Saudi Arabia have also increased dramatically over the 
years. A recent study from Riyadh9 showed that the 
susceptibilities of A. baumannii to meropenem and 
imipenem in 2006 ranged between 64-81.2%, while 
the susceptibility in 2012 ranged between 8.3-11%. 
Molecular investigation on different CRAB isolates 
obtained from all of the GCC states revealed that large 
number of isolates, from different states, have clustered 
together, suggesting clonality.10
The last-line resource antibiotic currently available 
to tackle many of carbapenem resistant GNB is colistin. 
However, colistin resistant and even pan-drug resistant 
GNB have already been reported. Colistin resistance is 
typically chromosomally mediated and generally not 
transmissible between bacteria. Nevertheless, the recent 
description of plasmid-mediated colistin resistance 
mechanism mcr-1 has enormous implications on the 
lifespan of colistin.11 Plasmid carrying mcr-1 was found 
in many parts of the world among Enterobacteriaceae 
and non-fermentative GNB.11 A recent report 
highlighted the presence of the mcr-1 gene in 4 E. coli 
that were isolated between 2012-2015 from Saudi 
Arabia, Bahrain, and the United Arab Emirates.12 It 
is likely though that mcr-1 carrying GNB are widely 
disseminated in more isolates and between other species 
in the Arabian Peninsula.
Other studies from the GCC region5,13 affirmed 
that the region harbours other rare and novel antibiotic 
resistance mechanisms. For example, PME-1 ESBL 
producing Pseudomonas aeruginosa (P. aeruginosa) from 
Qatar,13 and the pandrug-resistant K. pneumoniae from 
neighboring UAE.5 The latter report provides a very 
significant finding, as this breakthrough should raise 
the global attention to avoid the possible catastrophic 
future of AMR, which can be caused by such an 
untreatable pathogen.
A Saudi national surveillance on Gram-positive 
cocci demonstrated that 32% of Staphylococcus aureus 
(S. aureus) are methicillin-resistant (MRSA), and 33% 
of Streptococcus pneumoniae are resistant penicillin G 
and 26% are resistant to erythromycin.14 A study from 
Riyadh15 demonstrated that S. aureus was colonizing the 
nasal cavity of 40% of the 200 tested healthcare workers. 
Among those S. aureus, 45% were methicillin-resistant 
(MRSA), resulting in total prevalence of 18% health 
workers carrying MRSA. A national survey16 on anti-
tuberculosis drug resistance found that only 1.6% of 
total TB demonstrated MDR phenotype. These figures 
of high prevalence among different bacterial species in 
Saudi Arabia are unfortunately likely to be sustained, if 
not increased to due to several factors.
Local risk factors contributing to the emergence and 
spread of AMR. Several factors are associated to the 
increasing emergence and spread of MDR bacteria in 
Saudi Arabia. It is evident that the unoptimized use of 
antibiotics is a major factor for AMR development. A 
hospital in Riyadh has well demonstrated the overuse 
of antimicrobial agents from 4 adult ICUs in 2010, 
where the highest use was meropenem (33.2 defined 
daily doses [DDD] per 100 bed-days), followed by 
piperacillin-tazobactam (16.0 DDD/100 bed-days). 
On the other hand, the DDD/100 bed-days in 37 ICUs 
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in the United States was 3.75 for carbapenems and 7.08 
for antipseudomonal penicillins.7 Over-the-counter 
antibiotics without prescription in Saudi community 
pharmacies is another issue that is driving the improper 
use of antibiotics. Only one out of 88 pharmacists in 
Eastern province refused to sell antibiotics without a 
prescription, and 77.6% of the pharmacies in Riyadh 
dispensed antibiotics without a prescription.7 To my 
knowledge these are no published evidences from 
Saudi Arabia demonstrating the use of antibiotics as a 
growth promoter. However, several reports, in fact, have 
described the isolation of various MDR GNB from 
food animal specimens.7
Heavy international travel activities are occurring due 
to the large population of expatriates and to pilgrimage 
the holy cities. Travel is a known risk factor for acquiring 
and transmitting infectious diseases, including those 
caused by antibiotic resistant bacteria. A recent study17 
showed that returned travellers from Hajj have acquired 
MDR A. baumannii and NDM producing E. coli during 
the Hajj event. Previous data from 2 major hospitals in 
Makkah showed that ceftazidime resistance is evident in 
24.6% of E. coli, 34.4% of K. pneumoniae, and 52.7% 
of P. aeruginosa. Another report showed that septicemia 
episodes in Makkah are increased by 16.5% during Hajj 
time due to the influx of international patients.7
Another issue that can contribute to the spread 
of AMR is the challenges related to the adherence 
of infection control practices. The hand hygiene 
compliance rate in a hospital in Makkah in 2011 was 
50.3%. The effectiveness of hand hygiene compliance 
was well demonstrated in controlling a nosocomial 
outbreak caused by carbapenem-resistant K. pneumoniae 
in Riyadh.7 Figure 1 illustrates the several factors that 
may contribute to the emergence and spread of AMR.
Immediate actions needed. To limit this alarming 
threat on human health, the World Health Organization 
launched the Global Action Plan on Antimicrobial 
Resistance.18 This plan was signed off by most of 
member states, including Saudi Arabia during the 
Figure 1 - Different factors can stimulate the emergence and spread of 
multidrug-resistant bacteria. 
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World Health Assembly in 2015. The plan consists of 
5 pillars; to improve awareness, stringing knowledge 
through surveillance, reduce the incidence of infection, 
optimize the use of antimicrobial agents, and develop 
the economic case for sustainable investment to support 
the need in all countries in regards to new medicines, 
diagnostic tools, vaccines, and other interventions. To 
have tailored strategies, different countries initiated their 
own national AMR action plans, and the most notable 
similarity between all action plans is the willingness 
to tackle the antimicrobial misuse in both human and 
animal/agricultural sectors.
Raising public, medical, and veterinary awareness of 
AMR is an important element that is urgently needed 
to tackle AMR in Saudi Arabia. Previous research7 
has shown that antibiotics are widely used in the 
community, without prescription, to treat unrelated 
scenarios. Multilevel and nationwide awareness 
campaigns in Saudi Arabia are needed to align with 
the World Antibiotic Awareness Week. The success of 
these campaigns can be dependent on the tailored and 
relevant content and key messages that are designed after 
formative research. The increasing use of social media 
platforms in the country can also help to disseminate 
awareness messages. It is very essential however, to 
consider all segments and socioeconomic groups in the 
Saudi society, as some members might not speak the 
local language, or actively use social media platform.19
Infection prevention and control plays a very 
important role to limit the spread of AMR. Conducting 
educational programs for healthcare workers regarding 
the importance of hand hygiene compliance can 
limit the spread of outbreak stains within hospitals, 
and potentially to the community.7 Hospitals might 
apply screening scheme for high-risk patients prior to 
admission to identify carriers of MDR pathogens and 
to apply isolation or contact precautions in order to 
limit spread.
Active ongoing surveillance on AMR is essential to 
aid the development of tailored treatment guidelines for 
empirical antibiotic therapy, particularly for community-
acquired infections. Developing local surveillance of 
AMR bacteria that are related to nosocomial infections 
can also helps to track emerging resistance to antibiotics 
and to identify outbreaks.7 Hence, microbiology 
laboratories should be well equipped to provide valid 
and reliable identification for pathogen, as well as 
antibiotic susceptibility tastings. As part of their routine 
services, microbiology laboratories should also be able 
to provide up-to-date antibiograms at a hospital level 
and contribute to local surveillance programs. With 
the widely accessible molecular-based techniques and 
Table 1 - Recommendations for actions to stakeholders in the Saudi Arabia to combat antimicrobial resistance.
Recommendations
Antimicrobial stewardship programs
Active guidelines should be implemented to restrict unnecessary use of antibiotics in Saudi hospitals.
Abolition of over-the-counter sales of antimicrobials without prescriptions. 
Regulations and strategies should be used to enforce the ban of antibiotics as growth-promoters in Saudi animal farms and restrict the use of important 
antimicrobials as listed by the World Health Organization - Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGSIR).
Initiating mass educational campaign about antibiotic use
To raise awareness about antibiotic resistance and limit the improper use of antibiotics. 
Cultural differences should be considered when implementing educational campaigns to be delivered to the population of Saudi Arabia.
The highly utilized social media platforms should be used to disseminate messages, but not solely.
Basic infection control precautions (for example, hand hygiene)
Should be emphasized among healthcare workers.
Patients who have been hospitalized internationally need to be screened by the receiving institute for multidrug-resistant organisms.
Infection prevention policy defining at-risk patients and management strategies (for example, empirical treatment, and isolation) should be developed.
Microbiology laboratories
Microbiologists should be updated with local, national, regional and international surveillance to prepare screening and confirmatory testing for emerging 
resistance mechanisms.
Molecular and protein-based identification tools should also be considered to improve diagnosis and to reduce turn-around time. 
Active surveillance
Developing local surveillance of antimicrobial resistant organisms in hospitals, regional and national levels to help suggesting empirical treatments and 
in outbreak tracking. 
Molecular-based techniques and whole genome sequencing should be utilized to give greater insight about the antibiotic resistance mechanisms and clone 
disseminations.
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whole genome sequencing, the use of these technologies 
on AMR can provide a richer insight on the clonal 
disseminations of certain species, and the genotypic 
characterization of antibiotic resistance mechanisms.7 
Surveillance in Saudi Arabia can help contribute to the 
global understanding of the burden of the AMR, which 
is still poorly quantified.2 It was suggested that countries 
should introduce death register records “deaths caused 
by antimicrobial-resistant infection”.6
Last but not least, active antibiotic stewardship 
guidelines should be implemented to restrict the 
irrational use of antibiotics in Saudi Arabia. These 
guidelines should aim to reduce over prescription and 
misprescription of antibiotics in outpatient settings, 
community pharmacies, hospital, and agricultural 
sectors. The WHO and Advisory Group on Integrated 
Surveillance of Antimicrobial Resistance (AGSIR) have 
published an updated list of antimicrobials according 
to their importance in human medicine.20 This list can 
immediately be used to control the use of medically 
important antimicrobials from food animal and 
agricultural settings in Saudi Arabia. Table 1 summarizes 
actions needed to tackle AMR in Saudi Arabia.
In conclusion, AMR is a global issue that requires 
tremendous attention. International agencies have 
suggested recommendations and plans to combat AMR. 
It is now up to countries to take the lead and implement 
local actions plans to limit AMR. Saudi Arabia faces 
several challenges that can stimulate the emergence 
and spread of MDR bacteria. These challenges require 
cultivated efforts from different sectors to successfully 
achieve a significant control of AMR in the country. 
Actions should include active surveillance of AMR 
on hospital-based, regional, and nationwide levels. 
Infection prevention and control precautions should 
also be optimized to limit the spread. Raising awareness 
of AMR is an essential mandate to limit inappropriate 
use of antibiotics, and the use of antimicrobial should 
be maintained by antibiotic stewardship programs not 
only in hospital settings, but also in outpatients and 
community pharmacies.
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